ASPAC II Acquisition Corp. Files 8-K

TL;DR

ASPAC II Acquisition Corp. filed a routine 8-K, no major news.

AI Summary

ASPAC II Acquisition Corp. filed an 8-K on July 19, 2024, reporting events as of July 18, 2024. The filing is a standard current report and does not contain specific details about material events, acquisitions, or financial performance beyond its classification as a blank check company.

Why It Matters

This filing indicates that ASPAC II Acquisition Corp. is fulfilling its reporting obligations as a publicly traded entity, which is standard for SPACs.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for a SPAC and does not disclose any new material risks or events.

Key Players & Entities

• ASPAC II Acquisition Corp. (company) — Filer of the 8-K report
• 0001213900-24-062772 (filing_id) — Accession number for the 8-K filing
• July 18, 2024 (date) — Date of the earliest event reported
• July 19, 2024 (date) — Date the report was filed

FAQ

Filing Documents

• ea0209624-8k_aspac2.htm (8-K) — 45KB
• 0001213900-24-062772.txt ( ) — 276KB
• ascb-20240718.xsd (EX-101.SCH) — 4KB
• ascb-20240718_def.xml (EX-101.DEF) — 27KB
• ascb-20240718_lab.xml (EX-101.LAB) — 38KB
• ascb-20240718_pre.xml (EX-101.PRE) — 26KB
• ea0209624-8k_aspac2_htm.xml (XML) — 8KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure As previously disclosed in its definitive proxy statement dated as of July 5, 2024 ("Definitive Proxy Statement"), A SPAC II Acquisition Corp. (the "Company") will hold an extraordinary general meeting of its shareholders on July 23, 2024 (the "Special Meeting") to consider and vote upon the Extension Amendment Proposal (as defined in the Definitive Proxy Statement) and, if necessary, the Adjournment Proposal (as defined in the Definitive Proxy Statement). The Company has identified two potential business combination target companies, one in the biofuel technology sector (the "Potential Biofuel Target"), and the other in the copper mining sector (the "Potential Mining Target," collectively, the "Potential Targets") for an initial business combination (the "Potential Business Combination"). The Company believes the Potential Business Combination with either Potential Target would represent a compelling opportunity for the Company to complete its initial business combination and has entered into a non-exclusive letter of intent with each of the Potential Targets. Neither letters of intent contemplate a minimum cash closing condition. Such letters of intent have no legal binding effect on either the Company or the Potential Targets. The Potential Biofuel Target is based in Vietnam, and according to the Potential Biofuel Target, it is one of the leading manufacturers of ethanol in Vietnam, with operators having over two decades of history and experience in the industry. According to the Potential Biofuel Target, it operates a bio-ethanol factory, specializing in producing high-quality ethanol products, such as 99% fuel ethanol, which is blended with traditional gasoline for vehicle use, 95%-95.5% solvent alcohol to be used in paint thinners, inks, and cleaning solvents, and 96% food alcohol for use in the alcohol processing and cosmetics industries. Byproducts from ethanol production, namely carbon dioxide and organic matter, ar

Forward-Looking Statements

Forward-Looking Statements Certain statements made in this Current Report are forward-looking "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: the risk that approval of the Company's shareholders for the Extension is not obtained; the inability of the Company to enter into a definitive agreement with respect to an initial business combination within the time provided in the Company's amended and restated memorandum and articles of association; the level of redemptions made by the Company's shareholders in connection with the Extension and its impact on the amount of funds available in the Company's trust account to complete an initial business combination; and those factors discussed in the Annual Report under the heading "Risk Factors," and other documents of the Company filed, or to be filed, with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

01. Other Events

Item 8.01. Other Events As previously disclosed in our Current Report on Form 8-K filed with the SEC on July 27, 2023, the Company was in preliminary talks to enter into a letter of intent with a potential business combination target company in the medical technology sector (the "Potential Medical Target"). The discussions between the Company and the Potential Medical Target have ended, and the parties did not enter into a letter of intent. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. A SPAC II ACQUISITION CORP. Dated: July 19, 2024 By: /s/ Serena Shie Name: Serena Shie Title: Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR